Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genome editing of graft-derived T-cells for post-transplant immunotherapy

Genome editing of graft-derived T-cells for post-transplant immunotherapy

US Patent 11903969 · Granted Feb 20, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Scarless genome editing through two-step homology directed repair2025
Materials and methods for treatment of hemoglobinopathies2024
Materials and methods for treatment of human genetic diseases including hemoglob2024
Materials and methods for treatment of hemoglobinopathies2024
Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated e2023
CRISPR/Cas 9-mediated integration of polynucleotides by sequential homologous re2023
Scarless genome editing through two-step homology directed repair2023
Pharmaceutical compositions comprising gene-corrected primary cells2023
Chemically modified guide RNAS for CRISPR/Cas-mediated gene regulation2022
Nuclease-mediated genome editing of primary cells2022
Chemically modified guide RNAs for CRISPR/CAS-mediated gene regulation2022
Nuclease-mediated genome editing of primary cells and enrichment thereof2021